Suchergebnisse - "Zenz, Thorsten"

PubPharm (10)

1

Genetics of "high-risk" chronic lymphocytic leukemia in the times of chemoimmunotherapy

enthalten in: Haematologica | 2020

von Ring, A. | Zenz, T.

CommentOn: Haematologica. 2020 May;105(5):1379-1390. - PMID 31467127

2

Mutational landscape and complexity in CLL

enthalten in: Blood | 2015

von Zenz, T. | Huber, W.

CommentOn: Blood. 2015 Oct 29;126(18):2110-7. - PMID 26316624

3

Exhausting T cells in CLL

enthalten in: Blood | 2013

von Zenz, T.

CommentOn: Blood. 2013 Feb 28;121(9):1612-21. - PMID 23247726

4

Improving treatment for chronic lymphocytic leukemia by rational use of monoclonal antibodies

enthalten in: Leukemia & lymphoma | 2012

von Słabicki, M. | Zenz, T.

CommentOn: Leuk Lymphoma. 2012 Nov;53(11):2218-27. - PMID 22475085

5

CLL 17p deletion : more than 'miR'ly p53?

enthalten in: Blood | 2010

von Zenz, T. | Stilgenbauer, S.

CommentOn: Blood. 2010 Aug 12;116(6):945-52. - PMID 20393129

6

MDM2 promotor polymorphism and disease characteristics in CLL

enthalten in: Leukemia research | 2010

von Zenz, T. | Benner, A. | Stilgenbauer, S.

CommentOn: Leuk Res. 2010 Mar;34(3):335-9. - PMID 19573916

7

Immunoglobulin heavy chain variable gene usage and (super)-antigen drive in chronic lymphocytic leukemia

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2010

von Bühler, A. | Zenz, T. | Stilgenbauer, S.

CommentOn: Clin Cancer Res. 2010 Jan 15;16(2):620-8. - PMID 20068100

8

More (on) prognostic factors in chronic lymphocytic leukemia

enthalten in: Leukemia & lymphoma | 2010

von Zenz, T. | Fulda, S. | Stilgenbauer, S.

CommentOn: Leuk Lymphoma. 2010 Jan;51(1):95-106. - PMID 20001236

9

Biological diversity and risk-adapted treatment of chronic lymphocytic leukemia

enthalten in: Haematologica | 2010

von Zenz, T. | Mertens, D. | Stilgenbauer, S.

CommentOn: Haematologica. 2010 Sep;95(9):1519-25. - PMID 20421269

10

Therapy with the FCR regimen does not overcome chronic lymphocytic leukemia biology : aberrant p53 expression predicts response and survival

enthalten in: Leukemia & lymphoma | 2009

von Zenz, T. | Stilgenbauer, S.

CommentOn: Leuk Lymphoma. 2009 Oct;50(10):1597-605. - PMID 19863337

1
[1]